Biomarkers in Cancer Screening and Early Detection
John Wiley & Sons Inc (Hersteller)
978-1-118-46886-9 (ISBN)
- Keine Verlagsinformationen verfügbar
- Artikel merken
Offers a comprehensive, state-of-the-art perspective on the various research and clinical aspects of cancer biomarkers
Provides immediately actionable information ? and hopefully also inspiration ? to move discovery and clinical application forward
Offers vital knowledge to help develop personalized cancer treatment for individual patients with specific cancers
Edited by Sudhir Srivastava, Ph.D., MPH Senior Scientific Officer, Chief, Cancer Biomarkers Research Group, Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA Translational Oncology Series Series Editors ROBERT C. BAST, MD, Vice President for Translational Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA MAURIE MARKMAN, MD, Senior Vice President for Clinical Affairs, Cancer Treatment Centers of America, Clinical Professor of Medicine, Drexel University College of Medicine, Philadelphia, PA, USA ERNEST HAWK, MD, MPH, Vice President, Division of OVP, Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
| Erscheint lt. Verlag | 10.6.2017 |
|---|---|
| Verlagsort | New York |
| Sprache | englisch |
| Maße | 150 x 250 mm |
| Gewicht | 666 g |
| Themenwelt | Naturwissenschaften ► Biologie |
| ISBN-10 | 1-118-46886-4 / 1118468864 |
| ISBN-13 | 978-1-118-46886-9 / 9781118468869 |
| Zustand | Neuware |
| Haben Sie eine Frage zum Produkt? |
aus dem Bereich
